Allergy Therapeutics (AGYTF)

Last Closing Price: --

Receiveable Turnover (Quarterly)

Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable

Allergy Therapeutics (AGYTF) Receiveable Turnover data is not available.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Balance Sheet Financials
$44.88M
$56.20M
$67.34M
$87.41M
$35.19M
$75.33M
$88.70M
$123.89M
$-36.50M
$-41.99M
$-36.48M
--
Cash Flow Statement Financials
$-36.38M
$-3.73M
$40.33M
$16.71M
$16.55M
$-0.16M
--
--
--
Fundamental Metrics & Ratios
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Receiveable Turnover
--
--
--
--
--
--
--
--
--